Wasatch Advisors Inc. Buys 1,997 Shares of CVS Health Corp (CVS)

Wasatch Advisors Inc. boosted its stake in CVS Health Corp (NYSE:CVS) by 2.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,060 shares of the pharmacy operator’s stock after purchasing an additional 1,997 shares during the period. Wasatch Advisors Inc.’s holdings in CVS Health were worth $6,924,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CVS. Horan Capital Advisors LLC. grew its stake in shares of CVS Health by 3.2% during the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after acquiring an additional 1,000 shares in the last quarter. Community Bank N.A. lifted its position in shares of CVS Health by 7.3% during the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after purchasing an additional 1,362 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of CVS Health by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after purchasing an additional 5,478 shares during the last quarter. Midwest Investment Management LLC lifted its position in shares of CVS Health by 6.2% during the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after purchasing an additional 1,245 shares during the last quarter. Finally, Fiduciary Trust Co. lifted its position in shares of CVS Health by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after purchasing an additional 4,265 shares during the last quarter. Hedge funds and other institutional investors own 82.24% of the company’s stock.

In other CVS Health news, COO Jonathan C. Roberts sold 85,743 shares of the firm’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $83.14, for a total value of $7,128,673.02. Following the sale, the chief operating officer now owns 119,555 shares in the company, valued at $9,939,802.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the sale, the executive vice president now owns 43,178 shares in the company, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. Insiders sold 145,630 shares of company stock worth $12,017,632 in the last three months. 0.61% of the stock is currently owned by corporate insiders.

Several brokerages have recently commented on CVS. Jefferies Group set a $76.00 price target on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Needham & Company LLC increased their price target on shares of CVS Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research report on Monday, December 4th. Loop Capital set a $73.00 price target on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Robert W. Baird set a $77.00 price target on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Finally, Citigroup reduced their price target on shares of CVS Health from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Thursday, August 17th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $86.35.

Shares of CVS Health Corp (NYSE CVS) traded down $1.19 during midday trading on Wednesday, reaching $71.66. 2,241,887 shares of the company’s stock were exchanged, compared to its average volume of 6,955,034. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 1 year low of $66.45 and a 1 year high of $84.72. The company has a market capitalization of $74,029.46, a PE ratio of 12.80, a P/E/G ratio of 1.37 and a beta of 0.89.

CVS Health (NYSE:CVS) last issued its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. During the same quarter last year, the company posted $1.64 earnings per share. CVS Health’s revenue was up 3.5% on a year-over-year basis. research analysts anticipate that CVS Health Corp will post 5.9 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/13/wasatch-advisors-inc-buys-1997-shares-of-cvs-health-corp-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply